Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita Fazzi

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Antiviral Research|December 5, 2006
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidoneDaniele Focosi, Rita Fazzi, Domenico Montanaro, et al.
Leukemia Research|January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo studySara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Stem Cells and Development|February 6, 2013
Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cellsSimone Pacini, Rita Fazzi, Marina Montali, et al.
Plos One|October 8, 2011
Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathwayRita Fazzi, Simone Pacini, Vittoria Carnicelli, et al.
British Journal of Haematology|August 20, 2008
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-upGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Stem Cells and Development|April 1, 2009
Selective culture of mesodermal progenitor cellsLuisa Trombi, Simone Pacini, Marina Montali, et al.
Leukemia Research|September 27, 2005
Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategyEnrico Orciuolo, Rita Fazzi, Sara Galimberti, et al.
Stem Cells and Development|March 16, 2016
Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone MarrowSimone Pacini, Serena Barachini, Marina Montali, et al.
Leukemia Research|July 20, 2002
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cellsRita Fazzi, Sara Galimberti, Rossana Testi, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Antiviral Research|December 5, 2006
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidoneDaniele Focosi, Rita Fazzi, Domenico Montanaro, et al.
Leukemia Research|January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo studySara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Stem Cells and Development|February 6, 2013
Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cellsSimone Pacini, Rita Fazzi, Marina Montali, et al.
Plos One|October 8, 2011
Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathwayRita Fazzi, Simone Pacini, Vittoria Carnicelli, et al.
British Journal of Haematology|August 20, 2008
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-upGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Stem Cells and Development|April 1, 2009
Selective culture of mesodermal progenitor cellsLuisa Trombi, Simone Pacini, Marina Montali, et al.
Leukemia Research|September 27, 2005
Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategyEnrico Orciuolo, Rita Fazzi, Sara Galimberti, et al.
Stem Cells and Development|March 16, 2016
Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone MarrowSimone Pacini, Serena Barachini, Marina Montali, et al.
Leukemia Research|July 20, 2002
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cellsRita Fazzi, Sara Galimberti, Rossana Testi, et al.
Pageof 5